Sojo LE

Xenon Pharmaceuticals (Canada)

1
Publications in this database

PubMed name variants: Sojo LE. Uses the same surname-and-first-initial grouping as the researcher table; matches are not verified identities.

15
Career-wide h-index · OpenAlex
(709 citations, 34 total works)

Career-wide Research Topics · OpenAlex

Topic counts cover the OpenAlex author’s full publication record, across all conditions.

Ion channel regulation and function (10)Pesticide Residue Analysis and Safety (7)Pesticide and Herbicide Environmental Studies (6)Mass Spectrometry Techniques and Applications (5)Metabolomics and Mass Spectrometry Studies (5)

Erythromelalgia Publications

Selective Na1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain.

Bankar G, Goodchild SJ, Howard S, Nelkenbrecher K, Waldbrook M, et al.
Cell reports •

Selective block of Na1.7 promises to produce non-narcotic analgesic activity without motor or cognitive impairment. Several Na1.7-selective blockers have been reported, but efficacy in animal pain models required high multiples of the IC for channel block. Here, we report a target engagement assay using transgenic mice that has enabled the development of a second generation of selective Nav1.7 inhibitors that show robust analgesic activity in inflammatory and neuropathic pain models at low multiples of the IC. Like earlier arylsulfonamides, these newer acylsulfonamides target a binding site on the surface of voltage sensor domain 4 to achieve high selectivity among sodium channel isoforms and steeply state-dependent block. The improved efficacy correlates with very slow dissociation from the target channel. Chronic dosing increases compound potency about 10-fold, possibly due to reversal of sensitization arising during chronic injury, and provides efficacy that persists long after the compound has cleared from plasma.